CN Patent

CN114786660A — 使用mtorc1调节剂的治疗方法

Assigned to Navitor Pharmaceuticals Inc · Expires 2022-07-22 · 4y expired

What this patent protects

本发明涉及可用于选择性调节mTORC1活性的方法、组合物及单位剂型。

USPTO Abstract

本发明涉及可用于选择性调节mTORC1活性的方法、组合物及单位剂型。

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN114786660A
Jurisdiction: CN
Classification: —
Expires: 2022-07-22
Drug substance claim: No
Drug product claim: No
Assignee: Navitor Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.